:{O]K^;-H'M+L}?}>XC),_FI|T8IA<
SYSTEM PROCESSING...
:{O]K^;-H'M+L}?}>XC),_FI|T8IA<
SYSTEM PROCESSING...
Posted: 2025-05-07 20:44:31 UTC

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-07 20:46:38 UTC
Verified By
Rollup News
New research indicates that psychedelics, such as psilocybin, have the ability to reshape the communication between the brain and the immune system, going beyond just altering neuronal functions. The study found that chronic stress can disrupt signaling in the amygdala, leading to immune responses that intensify feelings of fear and anxiety. Psychedelic compounds were able to reverse this process, resulting in reduced immune activity and a decrease in fear-related behaviors. This suggests that mental health disorders may be linked to immune dysfunction as much as neural imbalance, and that targeting neuroimmune circuits could revolutionize future treatments.
Psychedelics reset brain-immune communication disrupted by chronic stress.
This dual action may explain psychedelic benefits across psychiatric and inflammatory disorders.
Mental health treatments should target both neural and immune pathways.
Chronic stress disrupts signaling in the amygdala.
Immune responses heighten fear and anxiety.
Mental health disorders may involve immune dysfunction as much as neural imbalance.